Summary
Extracellular single unit recording and micro-iontophoretic studies were carried out in chloral hydrate-anesthetized and gallamine-paralyzed rats to investigate the actions of the enantiomers of the dopamine (DA) analogue 3-(3-hydroxyphenyl)-N-n-propylpiperidine, 3-PPP, on the nigrostriatal DA system. Intravenously administered (+)-or (−)-3-PPP consistently inhibited nigral DA neuronal activity; these actions were readily antagonized by haloperidol but were not affected by a pretreatment of reserpine plus alpha-methyltyrosine. In contrast to (+)-3-PPP, the (−)-enantiomer produced only partial inhibition of the majority of cells studied and was also capable of partially reversing the inhibitory action of apomorphine. A prior hemitransection of the brain did not alter the inhibitory action of either enantiomer. Whereas iontophoretically ejected (+)-3-PPP consistently reduced DA cell firing rate, similarly applied (−)-3-PPP reduced the activity of only some DA cells, while the majority were not influenced. In addition, iontophoresis of (−)-3-PPP could reduce the inhibitory effect of similarly applied DA or (+)-3-PPP. The (+)-enantiomer reduced caudate neuronal activity both after intravenous administration and iontophoresis. Intravenously administered (−)-3-PPP failed to influence or increased the activity of these neurons and reversed the inhibitory action of apomorphine. However, iontophoretically ejected drug reduced caudate cell activity and did not influence the inhibitory action of DA. The activity of non-DA zona reticulata neurons was inconsistently influenced by the 3-PPP enantiomers. It is concluded that (+)-3-PPP is a directly acting DA agonist, stimulating both DA autoreceptors and postsynaptic DA receptors. In contrast, (−)-3-PPP appears to be a partial agonist at nigral DA autoreceptors, whereas the action of the drug at putative postsynaptic DA receptors in the caudate remains to clarified.
Similar content being viewed by others
References
Aghajanian CK, Bunney BS (1977) Dopamine “autoreceptors”: Pharmacological characterization by microiontophoretic single cell recording studies. Naunyn-Schmiedeberg's Arch Pharmacol 297:1–7
Arbilla S, Langer S (1984) Differential effects of the stereoisomers of 3-PPP on dopaminergic and cholinergic neurotransmission in superfused slices of the corpus striatum. Naunyn-Schmiedeberg's Arch Pharmacol 327:6–13
Arnt J, Bogeso KP, Christensen AV, Hyttel J, Larsen JJ, Svendsen O (1983a) Dopamine agonistic and antagonistic effects of the 3-PPP enantiomers. Psychopharmacol 81:199–207
Arnt J, Christensen AV, Hyttel J, Larsen JJ, Svendsen O (1983b) Effects of putative autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity. Eur J Pharmacol 86:185–198
Arnt J, Hyttel J (1984) Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats. J Neural Transm 60:205–223
Atack CV (1973) The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay. Br J Pharmacol 48:699–714
Atack CV, Magnusson T (1978) A procedure for the isolation of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from tissue samples using a single column of strongly acidic cation exchange resin. Acta Pharmacol Toxicol 42:35–57
Baring MD, Walters JR, Eng N (1980) Action of systemic apomorphine on dopamine cell firing after neostriatal kainic acid lesion. Brain Res 181:214–218
Bloom F (1975) To spritz or not to spritz: The doubtful value of aimless iontophoresis. Life Sci 14:1819–1834
Bunney BS, Aghajanian GK (1978) d-Amphetamine-induced depression of central dopamine neurons: Evidence for mediation by both autoreceptors and a striato-nigral feedback pathway. Naunyn-Schmiedeberg's Arch Pharmacol 304:255–261
Bunney BS, Meltzer LT, Kauer JA, Chiodo LA (1983) (+)-3-PPP: A selective dopamine autoreceptor agonist? Electrophysiological studies in the basal ganglia. In: Carlsson A, Nilsson JLC (eds) Dopamine receptor agonists. Acta pharmaceutica suecica. Swedish Pharmaceutial Press, Sweden, Suppl 1, pp 138–144
Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973) Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:561–571
Carlsson A (1978) Mechanism of action of neuroleptic drugs. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: A generation of progress. Raven Press, New York, pp 1057–1070
Carlsson A (1983) Dopamine receptor agonists. Intrinsic activity vs. state of receptor. J Neural Transm 57:309–315
Chiodo LA, Bunney BS (1983) Electrophysiological studies on EMD 23448, an indolyl-3-butylamine, in the rat: A putative selective dopamine autoreceptor agonist. Neuropharmacology 9:1087–1093
Chiodo LA, Bunney BS (1984) Effects of dopamine antagonists on midbrain dopamine cell activity. In: Usdin E, Carlsson A, Dahlström A, Engel J (eds) Catecholamines, Part B, Neuropharmacology and central nervous system-theoretical aspects. Alan R Liss, Inc, New York, pp 369–391
Clark D, Carlsson A, Hjorth S, Engel J, Lindberg P (1983) The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat. Psychopharmacology 81:14–17
Clark D, Engberg G, Pileblad E, Svensson TH, Carlsson A, Freeman AS, Bunney BS (1984a) The effects of novel dopaminergic agonists on the nigrostriatal dopamine system. Clin Neuropharmacol 7, suppl I, p 45
Clark D, Hjorth S, Carlsson A (1984b) (+)- and (−)-3-PPP exhibit different intrinsic activity on striatal DA autoreceptors controlling DA synthesis. Eur J Pharmacol 105:185–189
Clark D, Hjorth S, Carlsson A (1985a) Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity. I. A review of the evidence. J Neural Transm (in press)
Clark D, Hjorth S, Carlsson A (1985b) Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. J Neural Transm (in press)
Corsini GV, Del Zompo M, Manconi S, Cianchetti C, Mangoni A, Gessa GL (1977) Sedative, hypnotic and antipsychotic effects of low doses of apomorphine in man. Adv Biochem Psychopharmacol 16:645–648
Domesick VB (1981) The anatomical basis for feedback and feedforward in the striatonigral system. In: Corsini GV, Gessa GL (eds) Apomorphine and other dopaminomimetics, vol 1, Basic pharmacology. Raven Press, New York, pp 27–39
Elam M, Clark D, Svensson TH (1985) Effects of the enantiomers of 3-PPP on locus coeruleus neurons in the rat (submitted)
Eriksson E, Modigh K, Carlsson A, Wikström H (1983) Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers. Eur J Pharmacol 96:29–36
Fielding S, Lal H (1978) Behavioral actions of neuroleptics. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 10. Plenum Press, New York, pp 91–128
Grace AA, Bunney BS (1979) Paradoxical GABA excitation of nigral dopaminergic cells: Indirect mediation through reticulata inhibitory neurons. Eur J Pharmacol 59:211–218
Grace AA, Bunney BS (1980) Nigral dopamine neurons: Intracellular recording and identification with l-dopa injection and histofluorescence. Science 210:654–656
Grace AA, Bunney BS (1984) Electrophysiology of nigral dopamine neurons: Characterization by intracellular and extracellular recording. In: Usdin E, Carlsson A, Dahlström A, Engel J (eds) Catecholamines, part B, Neuropharmacology and central nervous system — theoretical aspects. Alan R Liss, Inc, New York, pp 323–332
Haigler HJ, Aghajanian GK (1974) Lysergic acid diethylamide and serotonin: A comparison of effects on serotonergic neurons and neurons receiving a serotonergic input. J Pharmacol Exp Ther 188:688–689
Hjorth S (1983) On the mode of action of 3-(3-hydroxyphenyl)-N-n-propylpiperidine, 3-PPP, and its enantiomers. Acta Physiol Scand Suppl 517 (Thesis) pp 1–52
Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson A, Nilsson JLG (1983) Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology 81:89–99
Hjorth S, Carlsson A, Wikström H, Lindberg P, Sanchez D, Hacksell U, Arvidsson LE, Svensson U, Nilsson JLG (1981) 3-PPP, a new centrally acting DA receptor agonist with selectivity for autoreceptors. Life Sci 28:1225–1238
Hjorth S, Clark D, Carlsson A (1984) 3-PPP enantiomers and brain sigma opiate sites: discrepancies between in vitro and in vivo observations. Presented at “Dopamine 84” symposium, Southampton, England (in press)
Jeste DV, Cutler NR, Kaufman CA, Karoum F (1983) Low-dose apomorphine and bromocryptine in neuroleptic-induced movement disorders. Biol Psychiatry 18:1085–1091
Koch SW, Koe BK, Bacopoulos NG (1983) Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites. Eur J Pharmacol 92:279–283
König JFR, Klippel RA (1970) The rat brain: A stereotaxic atlas. Kriege, New York
Largent BL, Gundlach AL, Snyder SH (1984) Psychotomimetic opiate receptors labelled and visualized with (+)-3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. Proc Natl Acad Sci USA 81:4983–4987
Markstein R, Lahaye D (1983) In vitro effect of the racemic mixture and the (−)enantiomer of N-n-3-(3-Hydroxyphenyl)-piperidine (3-PPP) on postsynaptic dopamine receptors and on a presynaptic dopamine autoreceptor. J Neural Transm 58:43–53
Martin GE, Haubrich DR, Williams M (1981) Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and Tl-99. Eur J Pharmacol 76:15–23
Mereu G, Fanni B, Gessa GL (1984) General anesthetics prevent dopaminergic nerve stimulation by neuroleptics. In: Usdin E, Carlsson A, Dahlström A, Engel J (eds) Catecholamines, part B, Neuropharmacology and central nervous system — theoretical aspects. Alan R Liss, Inc, New York, pp 353–358
Plantjc JF, Hansen HA, Daus FJ, Stoof JC (1984) The effects of SCH 23390, YM 09151-2, (+)- and (−)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro. Eur J Pharmacol 105:73–83
Salmoiraghi GC, Weight F (1967) Micromethods in neuropharmacology: An approach to the study of anesthesia. Anesthesiology 28:54–64
Schordoret M, Hjorth S, Hacksell U (1984) Differential effects of the enantiomers of 3-PPP on dopamine d1-receptors of isolated rabbit retina. J Neural Transm 59:1–7
Seeman P (1980) Brain dopamine receptors. Pharm Revs 32:229–313
Siggins GR, Hoffer BJ, Ungerstedt U (1974) Electrophysiological evidence for involvement of cyclic adenosine monophosphate in dopamine responses of caudate neurons. Life Sci 15:779–792
Skirboll L, Bunney BS (1979) The effects of acute and chronic haloperidol treatment on spontaneously firing neurons in the caudate nucleus of the rat. Life Sci 25:1419–1434
Skirboll L, Grace AA, Bunney BS (1979) Dopamine auto- and postsynaptic receptors: Electrophysiological evidence for differential sensitivity to dopamine agonists. Science 206:80–82
Smith RC, Tamminga CA, Davis JM (1977) Effect of apomorphine on schizophrenic symptoms. J Neural Transm 40:171–176
Tamminga CA, Schaffer MH, Smith RC, Davis JM (1978) Schizophrenic symptoms improve with apomorphine. Science 200:567–568
Tasaki K, Tsukahara U, Ito S, Wayner MJ, Yu WY (1968) A simple, direct and rapid method for filling microelectrodes. Physiol Behav 3:1009–1010
Trulson ME, Trulson VM (1982) Chloral hydrate anesthesia alters the responsiveness of dorsal raphe neurons to psychoactive drugs. Life Sci 32:949–956
Walters JR, Bunney BS, Roth RH (1975) Pirebedil and apomorphine: Pre- and postsynaptic effects on dopamine synthesis and neuronal activity. In: Calne DB, Chase TN, Barbeau A (eds) Advances in neurology, vol 9. Raven Press, New York, pp 273–283
Walters JR, Roth RH (1976) Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch Pharmacol 296:5–14
Wang RY (1981) Dopaminergic neurons in the rat ventral tegmental area. II. Evidence for autoregulation. Brain Res Rev 3:141–153
Wang RY, White FJ, Voigt MM (1984) Effects of dopamine agonists on midbrain dopamine cell activity. In: Usdin E, Carlsson A, Dahlström A, Engel J (eds) Catecholamines, part B, Neuropharmacology and central nervous system-theoretical aspects. Alan R Liss, Inc, New York, pp 359–367
White F, Wang RY (1984) A 10 dopamine neurons: Role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci 34:1161–1170
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clark, D., Engberg, G., Pileblad, E. et al. An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system. Naunyn-Schmiedeberg's Arch. Pharmacol. 329, 344–354 (1985). https://doi.org/10.1007/BF00496366
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00496366